In his latest research note, analyst Lisa Bedell Clive confirms his recommendation. The broker Bernstein is keeping its Neutral rating. The target price is unchanged at EUR 73.
MarketScreener with dpa-AFX Analyser 2021
|
|
|
|
|
||||
|
||||
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short Term | Mid-Term | Long Term | |
Trends | Neutral | Neutral | Neutral |
Income Statement Evolution
Consensus
Sell |
|
Buy |
Mean consensus | OUTPERFORM |
Number of Analysts | 21 |
Average target price | 96,08 $ |
Last Close Price | 86,52 $ |
Spread / Highest target | 29,6% |
Spread / Average Target | 11,1% |
Spread / Lowest Target | -24,7% |